Data / Form D filings / GRANATA BIO Corp
GRANATA BIO Corp: Form D filings
GRANATA BIO Corp, a biotechnology company in Duxbury, MA, filed 2 Form D notices with the SEC between 2023 and 2024. The latest, on December 31, 2024, reports $13.8 million sold of a $15 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 289 ST GEORGE STREET, SUITE 209, Duxbury, MA, 02332
- Phone
- (617) 620-2640
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1773867
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | New notice | $14,999,999 | $13,765,000 | $1,234,999 | 3 | Dec 19, 2024 | sec.gov |
| Nov 6, 2023 | New notice | $13,999,999 | $10,094,226 | $3,905,773 | 10 | Oct 25, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| EVAN SUSSMAN | Executive Officer, Director | |
| SARAH FARANDA | Executive Officer, Director | |
| EDUARDO HARITON | Director | |
| DAVID PALLER | Executive Officer, Director | |
| PETER TUREK | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Dec 30, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what GRANATA BIO Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.